Loss of chromosome 1 in myxopapillary ependymoma suggests a region out of chromosome 22 as critical for tumour biology: A FISH analysis of four cases on touch imprint smears

Cytopathology

Volumn 17, Issue 4, 2006, Pages 199-204

  Tamiolakis, D ^a   Papadopoulos, N ^b   Venizelos, I ^c   Lambropoulou, M ^b   Nikolaidou, S ^a   Bolioti, S ^a   Kiziridou, A ^d   Manavis, J ^b   Alexiadis, G ^b   Simopoulos, C ^b  

^a Regional Hospital of Chania   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c Ippokration Hospital Thessaloniki   (Greece)

^d Department of Pathology   (Greece)

Author keywords

Chromosomes 1 and 22; Double target FISH; Ependymoma; Tumour imprint cytology smears

Indexed keywords

ADULT; ARTICLE; CHROMOSOME 1; CHROMOSOME 1P; CHROMOSOME 22; CHROMOSOME 22Q; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; EPENDYMOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RELAPSE; SMEAR; TUMOR SUPPRESSOR GENE;

ADULT; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 22; CYTODIAGNOSIS; EPENDYMOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED;

EID: 33746433011     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00287.x     Document Type: Article

References (30)

1. Suzuki S, Oka H, Kawano N, Tanaka S, Utsuki S, Fujii K. Prognostic value of Ki -67 (MIB1) and p53 in ependymomas. Brain Tumor Pathol 2001;18:151-4.
2. Hamilton RL, Pollack IF. The molecular biology of ependymomas. Brain Pathol 1997;7:807-22.
3. Ransom DT, Ritland SR, Kimmel DW et al. Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas. Genes Chromosome Cancer 1992;5:348-56.
4. Rogatto SR, Casartelli C, Rainho CA, Barbieri-Neto J. Chromosomes in the genesis and progression of ependymomas. Cancer Genet Cytogenet 1993;69:146-52.
5. Stratton MR, Darling J, Lantos PL, Cooper CS, Reeves BR. Cytogenetic abnormalities in human ependymomas. Int J Cancer 1989;44:579-81.
6. Weremowicz S, Kupsy WJ, Morton CC, Fletcher JA. Cytogenetic evidence for a chromosome 22 tumour suppressor gene in ependymoma. Cancer Genet Cytogenet 1992;61:193-6.
7. Wernicke C, Thiel G, Lozanova T et al. Involvement of chromosome 22 in ependymomas. Cancer Genet Cytogenet 1995;79:173-6.
8. Bijlsma EK, Voesten AM, Bijleved EH et al. Molecular analysis of genetic changes in ependymomas. Genes Chromosome Cancer 1995;13:272-7.
9. Sawyer JR, Sanmartino G, Husain M, Boop FA, Chadduck WM. Chromosome aberrations in four ependymomas. Cancer Genet Cytogenet 1994;74:132-8.
10. Dal Cin P, Sandberg AA. Cytogenetic findings in a supratentorial ependymoma. Cancer Genet Cytogenet 1988;30:289-93.
11. Sainati L, Montaldi A, Putti MC et al. Cytogenetic t(11;17)(q13;q21) in a pediatric ependymoma. Is 11q13 a recurring breakpoint in ependymoma? Cancer Genet Cytogenet 1992;59:213-6.
12. Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 1989;41:153-74.
13. Bigner SH, Mark J, Friedman HS, Biegel JA, Bigner DD. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet 1988;30:91-101.
14. Hashimoto N, Ichikawa D, Arakawa Y et al. Frequent deletions of material from chromosome arm 1p in oligodendroglial tumours revealed by double-target fluorescence in situ hybridization and microsatellite analysis. Genes Chromosome Cancer 1995;14:295-300.
15. Bello MJ, Leone PE, Nebreda P et al. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 1995;83:160-4.
16. Griffin CA, Long PP, Carson BS, Brem H. Chromosome abnormalities in low-grade central nervous system tumours. Cancer Genet Cytogenet 1992;60:67-73.
17. Jenkins RB, Kimmel DW, Moertel CA et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 1989;39:253-79.
18. Inazawa J, Ariyama T, Abe T. Physical ordering of three polymorphic DNA markers spanning the regions containing a tumour suppressor gene of renal cell carcinoma by three colour fluorescence in situ hybridization. Jpn J Cancer Res 1992;83:1248-52.
19. Nijssen PC, Deprez RH, Tijssen CC et al. Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumours cells. J Neurol Neurosurg Psychiatry 1994;57:1245-8.
20. Park JP, Chaffee S, Noll WW, Rhodes CH. Constitutional de novo t(1;22)(p22:q11-2) and ependymoma. Cancer Genet Cytogenet 1996;86:150-2.
21. Vagner-Capodano AM, Zattara-Cannoni H, Gambarelli D et al. Cytogenetic study of 33 ependymomas. Cancer Genet Cytogenet 1999;115:96-9.
22. Slavc I, Mac Collin MM, Dunn M et al. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumours and meningiomas. Int J Cancer 1995;64:243-7.
23. Sawyer JR, Crowson ML, Roloson GJ, Chadduck WM. Involvement of the short arm of chromosome 1 in a myxopapillary ependymoma. Cancer Genet Cytogenet 1991;54:55-60.
24. Ebert C, von Hacken M, Meyer-Puttlitz B et al. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 1999;155:627-32.
25. Egelhoff JC, Bates DJ, Ross JS. Spinal MR findings in neurofibromatosis types 1 and 2. Am J Neuroradiol 1992;13:1071-7.
26. Lee M, Rezai AR, Freed D, Epstein FJ. Intramedullary spinal cord tumours in neurofibromatosis. Neurosurgery 1996;38:32-7.
27. Louis D, Ramesh V, Gusella J. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumours. Brain Pathol 1995;5:163-72.
28. Rouleau G, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-21.
29. 2 tumour suppressor gene and of chromosome 22 deletions in gliomas. Int J Cancer 1995;60:478-81.
30. Neumann E, Kalousek DK, Norman MG, Steinbok P, Cochrane DD, Godoard K. Cytogenetic analysis of 109 pediatric central nervous tumours. Cancer Genet Cytogenet 1993;71:40-9.